市場調査レポート

商品コード

1458093

バイオプリザベーションの世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2024～2031年

Global Biopreservation Market Size, Share, Growth Analysis, By Product(Equipment, Media), By Application(Regenerative Medicine, Bio-banking) - Industry Forecast 2024-2031

出版日: 2024年03月24日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のバイオプリザベーション市場規模は2022年に21億8,000万米ドルと評価され、2023年の28億米ドルから2031年には205億4,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは28.30%で成長する展望です。

COVID-19パンデミックは、主にワクチン製造における製薬会社やバイオテクノロジー企業の研究開発努力の高まりにより、バイオプリザベーション市場に大きな影響を与えました。特に、Pfizer-BioNTech、Moderna、JanssenなどのmRNAワクチンは、超低温から冷蔵まで、出荷・保存条件が異なるため、特定のバイオプリザベーション技術が必要とされました。その結果、パンデミックの影響は、生殖医療、臓器移植、幹細胞バンク、遺伝子バンクなど様々な領域で重要な位置を占めるバイオプリザベーションセグメントに大きな影響を与えるものと考えられます。市場開拓の原動力となっているのは、医療支出の増加、医療施設における院内サンプル保存の普及、研究開発投資の拡大です。再生医療における組織や細胞の保存に対する需要の急増は、X-Therma Inc.の1,300万米ドルのシリーズA資金調達やOri Biotechの1億米ドルのシリーズB資金調達に代表されるように、バイオプリザベーションに特化した製薬企業への資金調達の増加を引き寄せています。企業家や製薬会社が生物保存企業に関心を持ち、支援することは、技術的進歩、製品承認、業界内の戦略的提携に支えられ、市場成長をさらに促進すると予想されます。英国のGuy's and St Thomas's fertility preservation service for ovarian tissue cryopreservationのようなイニシアチブは、バイオプリザベーションツールのコスト効率とともに、このセグメントにおける継続的な技術的進歩を強調するものであり、市場拡大の有望な展望を予告するものです。とはいえ、装置のコスト、メンテナンス費用、保存中の潜在的な組織損傷といった課題が、市場成長の障害となる可能性もあります。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

バイオプリザベーションの世界市場：製品別

市場概要
装置
メディア
研究室情報管理システム（LIMS）

バイオプリザベーションの世界市場：用途別

市場概要
再生医療
バイオバンク
創薬

バイオプリザベーションの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Thermo Fisher Scientific Inc.
Merck KGaA
BioLife Solutions, Inc.
GE Healthcare
VWR International LLC
Custom Biogenic Systems, Inc.
Chart Industries, Inc.
BioCision LLC
STEMCELL Technologies Inc.
Cesca Therapeutics Inc.
Core Dynamics Ltd.
Panasonic Healthcare Co., Ltd.
Avantor, Inc.
Lonza Group Ltd.
Brooks Automation, Inc.
BioStorage Technologies, Inc.
LabVantage Solutions, Inc.
Atlanta Biologicals, Inc.
Hamilton Company
So-Low Environmental Equipment Co.

Product Code: SQMIG35I2223

Global Biopreservation Market size was valued at USD 2.18 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 20.54 billion by 2031, growing at a CAGR of 28.30% during the forecast period (2024-2031).

The COVID-19 pandemic significantly impacted the biopreservation market, primarily due to heightened research and development efforts by pharmaceutical and biotech firms in crafting vaccines. Notably, mRNA vaccines such as Pfizer-BioNTech, Moderna, and Janssen necessitated specific biopreservation techniques owing to their distinct shipping and storage prerequisites, ranging from ultra-cold to refrigerated conditions. Consequently, the pandemic's influence is poised to be substantial on the biopreservation sector, which holds vital importance in various domains like reproductive medicine, organ transplantation, stem cell banking, and gene banking. Market expansion is fueled by escalated healthcare spending, the uptake of in-house sample storage in medical facilities, and amplified investments in research and development. The surge in demand for tissue and cell preservation in regenerative medicine has attracted augmented funding for biopreservation-focused pharmaceutical entities, exemplified by X-Therma Inc.'s USD 13 million Series A funding and Ori Biotech's USD 100 million Series B funding. Entrepreneurial and pharmaceutical interest in backing biopreservation firms is expected to further propel market growth, supported by technological advancements, product approvals, and strategic alliances within the industry. Initiatives like Guy's and St Thomas' fertility preservation service for ovarian tissue cryopreservation in the UK underscore the ongoing technological strides in the field, alongside the cost-efficiency of biopreservation tools, heralding promising prospects for market expansion. Nonetheless, challenges such as instrument costs, maintenance expenses, and potential tissue damage during preservation could pose obstacles to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segmental Analysis

The global biopreservation market is segmented based on product, application, and region. In terms of product, the market is segmented into equipment, media, and laboratory information management system (LIMS). Based on application, the market is segmented into regenerative medicine, bio-banking, drug discovery. Regionwise, the global biopreservation market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Biopreservation Market

The increasing emphasis on personalized medicine and tailored treatments has heightened the need for biopreservation solutions, essential for safeguarding biological samples such as cells, tissues, and organs, serving critical roles in research, diagnosis, and therapeutic endeavors.

Restraints in the Global Biopreservation Market

Biopreservation technologies and services often come with a hefty price tag, especially when considering long-term storage and extensive biobanking endeavors. The significant expenses involved in acquiring equipment, managing maintenance, and meeting operational demands can serve as a barrier, constraining the widespread implementation of biopreservation solutions, particularly in areas with limited resources.

Market Trends of the Global Biopreservation Market

The biopreservation market experiences a notable uptick in demand primarily fueled by the growing interest in cell-based treatments like stem cell and CAR-T cell therapies. The preservation of cell viability and functionality throughout storage and transportation is pivotal, accentuating the necessity for enhanced biopreservation methods and remedies.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Biopreservation Market by Product

Market Overview
Equipment
Media
and Laboratory Information Management System (LIMS)

Global Biopreservation Market by Application

Market Overview
Regenerative Medicine
Bio-banking
and Drug Discovery

Global Biopreservation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VWR International LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Custom Biogenic Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCision LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cesca Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Core Dynamics Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panasonic Healthcare Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brooks Automation, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioStorage Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabVantage Solutions, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlanta Biologicals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
So-Low Environmental Equipment Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments